ST百花(600721.SH):定增募資規模由不超4.1億元調減為不超3.893億元
格隆匯 1 月 7日丨ST百花(600721.SH)公佈,鑑於公司此次非公開發行募集資金投資項目的最新情況發生變化,公司對此次非公開發行股票的募集資金規模暨發行方案進行再次調整。
調整前:此次非公開發行所有發行對象均以現金方式認購此次非公開發行的股份,認購金額不超過人民幣4.1億元。
調整後:此次非公開發行所有發行對象均以現金方式認購此次非公開發行的股份,認購金額不超過人民幣3.893億元。
2021年1月7日,公司第七屆董事會第二十二次會議審議通過了《關於調減非公開發行股票募集資金規模暨調整發行方案的議案》,對此次非公開發行股票方案中的認購金額、募集資金用途等進行了調整。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.